deoxyribose has been researched along with Colonic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashton, AW; Hotchkiss, KA; Klein, RS; Lenzi, ML; Schwartz, EL; Zhu, GH | 1 |
Bruns, CJ; Doenecke, A; Frank, E; Geissler, EK; Guba, M; Jauch, KW; Koehl, GE; Seeliger, H; Steinbauer, M; Wagner, C | 1 |
2 other study(ies) available for deoxyribose and Colonic Neoplasms
Article | Year |
---|---|
Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration.
Topics: 5'-Nucleotidase; Alkaline Phosphatase; Breast Neoplasms; Cell Communication; Cell Movement; Chemotaxis; Colonic Neoplasms; Deoxyribose; Endothelium, Vascular; Enzyme Inhibitors; HT29 Cells; Humans; Monocytes; Ribosemonophosphates; Tumor Cells, Cultured | 2003 |
Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Aorta, Thoracic; Colonic Neoplasms; Deoxyribose; Disease Models, Animal; Fluorouracil; Immunosuppressive Agents; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Rats; Rats, Inbred ACI; Sirolimus; Thymidine Phosphorylase | 2004 |